Go to deals
Consumer & Retail | Healthcare

Periproducts Limited has been acquired by Venture Life Group plc

The private shareholders of Periproducts Limited have sold the company to Venture Life Group plc for US$8 million.

Perirpoducts is an independent, privately owned British company that produces and markets the award-winning UltraDEX Performance Oral Care range. Over the last 20 years, the company has been recognized for its innovative oral care products, incorporating the latest ingredients and technology, and backed by scientific research.

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercializing products for the ageing population. The group’s product range and pipeline currently include food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

Oaklins Cavendish, based in the UK, advised the seller in this transaction.

Parties

Talk to the deal team

Peter Gray

Partner
London, United Kingdom
Oaklins Cavendish

Related deals

Salmo Group has acquired SAENGER Top Tackle and Westline Angelgeräte
Consumer & Retail

Salmo Group has acquired SAENGER Top Tackle and Westline Angelgeräte

Salmo Group SIA, a Riga-based family-owned fishing products vendor, has acquired SAENGER Top Tackle GmbH and Westline Angelgeräte GmbH, German wholesale distributors of fishing tackle across Western Europe.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more